Abstract:Author(s): Fares-Frederickson, Nancy | Advisor(s): David, Michael | Abstract: Interferon regulatory factor 3 (IRF3) is a transcription factor found in the cytoplasm of most nucleated cells. Upon pathogen detection by pattern recognition receptors, IRF3 becomes activated and translocates to the nucleus where it mediates the production of type I interferon (IFN) and IFN-stimulated genes. The collective actions of these genes induce an antimicrobial state within infected and neighboring cells, allowing for pathogen clearance. Whereas the type I IFN system has been studied extensively in the context of pathogen responses, it has more recently become appreciated for its role in immune cell modulation. In this report we discuss novel findings highlighting the involvement of the type I IFN system—with a focus on IRF3—in T cell development, activation, differentiation, and cytokine production.Using a combination of in vitro assays and in vivo disease models, we demonstrate that IRF3 is a positive regulator of lL-17 and IFN-γ in CD4+ T cells. We show that IRF3-deficient CD4+ T cells have impaired production of the pro-inflammatory cytokines IL-17 and IFN-γ, and are unable to induce disease in the T cell transfer model of colitis. Unexpectedly, we observed IRF3 nuclear translocation in activated T cells. To our knowledge, this is the first description of IRF3 activation following T cell receptor stimulation. These results, which are the focus of chapter 1, reveal a previously unappreciated role for IRF3 in CD4+ T cell responses and extend its role beyond the innate immune response to pathogens.Additionally, we show that type I IFN limits T cell production of IL-2—a cytokine required for T cell activation and expansion—by indirectly altering histone modifications in the IL-2 promoter to retain the locus in an inaccessible configuration. These results, which are the focus of chapter 2, help explain why type I IFN has been an effective treatment for multiple sclerosis—a T cell- mediated autoimmune condition.

NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

Gcn5 and PCAF Negatively Regulate Interferon‐β Production Through HAT‐independent Inhibition of TBK1

P38 MAPK is Critical for Nuclear Translocation of IRF-7 During CpG-induced Type I IFN Expression in Human Plasmacytoid Dendritic Cells

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

P300, but Not PCAF, Collaborates with IRF-1 in Stimulating TRIM22 Expression, That is Independent on Its Histone Acetyltransferase Activity (P6336)

PACSIN1 regulates the TLR7/9-mediated type I interferon response in plasmacytoid dendritic cells.

BATF controls IFN I production via DC-SCRIPT in plasmacytoid dendritic cells

Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.

Plasmacytoid dendritic cell–specific receptor ILT7–FcεRIγ inhibits Toll-like receptor–induced interferon production

STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells

Beyond Innate Immunity: Defining a Role for Interferon Regulatory Factor 3 in CD4+ T Cell Responses

Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M

TRAF3 enhances type I interferon receptor signaling in T cells by modulating the phosphatase PTPN22

P300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression, that is independent on its histone acetyltransferase activity

Type I Interferon Activates PD-1 Expression Through Activation of the STAT1-IRF2 Pathway in Myeloid Cells

Characterization of a Novel Isoform of Murine Interferon Regulatory Factor 3

Interferon Regulatory Factor 3,A Pivotal Transcription Factor for Host Antiviral Responses: Interferon Regulatory Factor 3,A Pivotal Transcription Factor for Host Antiviral Responses

A lncRNA identifies IRF8 enhancer element in negative feedback control of dendritic cell differentiation

Type I interferon promotes the fate of Toll-like receptor 9–stimulated follicular B cells to plasma cell differentiation

Innate immune functions of plasmacytoid dendritic cells.